NEWS
_ Vifor Pharma releases further positive study results and expands the collaboration with Fresenius Medical Care
Tuesday, 29 June 2010 – Media release
_ CellCept® reaches positive results in Phase III trial in Lupus Nephritis
Thursday, 3 June 2010 – Media release
_ FAIR-HF subanalysis shows that Ferinject® improves kidney function in iron-deficient patients with chronic heart failure
Monday, 31 May 2010 – Media release
_ FAIR-HF study results show significant improvement in Chronic Heart Failure patients’ lives and give a new therapeutic option to healthcare professionals
Tuesday, 17 November 2009 – Media release
_ Integration of Aspreva completed - Vifor Pharma enters into a new phase
12 May 2009 – Media release
_ Galenica is making a strategic quantum leap with the aim of creating a new fully-integrated specialty pharma group
18 October 2007 – Media release
_ Further milestones achieved for Ferinject®
11 December 2007 – Media release
_ Venofer®: Closing of the US license agreement between Fresenius Medical Care and Luitpold Pharmaceuticals, Inc.
16 September 2008 – Media release
_ Galenica to establish a new partnership in the UK and Ireland
12 September 2008 – Media release
_ Galenica acquires Aspreva Pharmaceuticals Corporation
18 December 2007 – Media release
_ Takeover transaction for Aspreva closed
4 January 2008 – Media release
_ Injectafer® (Ferinject®): Recommendation of the FDA Advisory Committee:Recommendation for approval when oral iron treatment is ineffective
2 February 2008 – Media release
_ Injectafer® (Ferinject®): non-approvable letter received from the FDA
12 March 2008 – Media release
_ Galenica to establish its market position in Northern Europe
10 June 2008 – Media release
_ News 1/08: Specialty Pharma
24 June 2008 – Newsletter
_ Galenica promising launch for Ferinject® in Europe
24 June 2008 – Media release
_ Galenica and Fresenius Medical Care enter into a strategic joint-venture
9 July 2008 – Media release